Development Pipeline
Interleukin's product development is focused on the fact that certain genetic variations among individuals produce life-long differences in a person’s disease progression depending on lifestyle and environment. Interleukin's proprietary genetic technology helps to identify individuals who have a life-long tendency to over or under-express key chemicals in the body that lead to more disease or physical differentiation as they age. Individuals with these genetic differences also respond differently to certain treatments, diets, exercise or medication.
Our approach to test development is to create products that will benefit individuals seeking guidance for their particular conditions or illnesses. A genetic test must therefore be useful, understandable, and credible and serve as guidance for future action. The action resulting from the information provided by our genetic tests could be either some form of medical treatment, lifestyle change, or more careful monitoring of the person’s condition. It is important that a thorough understanding of the market potential for a potential genetic test be well understood prior to initiation of any research. Finally the company must be able to launch and sell a given product effectively.
  |